UroGen Pharma(URGN) - 2021 Q2 - Earnings Call Transcript

UroGen Pharma Ltd. (NASDAQ:URGN) Q2 2021 Earnings Conference Call August 4, 2021 8:30 AM ET Company Participants Sara Sherman - Head of Investor Relations Liz Barrett - President and CEO Jeff Bova - Chief Commercial Officer Mark Schoenberg - Chief Medical Officer Molly Henderson - CFO Conference Call Participants Leland Gershell - Oppenheimer Chris Howerton - Jefferies Ram Selvaraju - H.C. Wainwright Matt Kaplan - Ladenburg Thalmann Paul Choi - Goldman Sachs Operator Good morning, ladies and gentlemen, and ...